USPatentGranted
B2

Inhibitors of Bruton's tyrosine kinase

Granted 13 Oct 2015 · 2 office actions

Current assignee: Pharmacyclics · originally AbbVie Inc.

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Zhengying Pan, Lee Honigberg, Erik Verner · Examiner: Jeffrey H Murray · AU 1624 · TC 1600

Life of the patent

4 dated events
⤢ drag to zoom2007200820092010201120122013201420152016Prosecution
Prosecutionhover for detail · click to open

Abstract

Disclosed herein is a solid oral formulation comprising a therapeutically effective amount of a compound of Formula (A) formulated for release of the compound in the intestine, wherein the compound of Formula (A) has the structure: [structure]

Claims

13 · 1 independent · depth 7
12345678910111213
13 granted claims

Classifications

6 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K31/519
  • A61K9/48
  • A01N43/90
  • A61K45/06
  • A61K31/00
Section C — Chemistry; metallurgy
  • C07D487/04

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
1.7 y
636 days filing → grant
Office actions
1
after a restriction
Responses
2
no RCE
Interviews
1
examiner interview summaries
Examiner
Jeffrey H Murray
art unit 1624 · TC 1600
Citations: 444 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

2 priority documents
Priority
22 Sep 2006
earliest claimed
›Priority documents — 2
TypeDocumentDate
provisionalUS 6082672022 Sep 2006
related publicationUS 20140212485 A131 Jul 2014

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock